Assistance Publique–Hôpitaux de Paris (AP-HP) has selected Aiforia Technologies Plc as a partner for AI-assisted pathology image analysis in clinical diagnostics. The collaboration involves the use of the Aiforia Clinical AI solutions for...

Aiforia announces the CE-IVD mark of its Aiforia® Clinical AI Model for Lung Cancer; PD-L1 for assisting pathologists in the fast and accurate primary diagnosis of lung cancer. This latest AI model expands Aiforia’s portfolio of clinical...

Financing to accelerate Aiforia’s development and continuing expansion of AI solutions for image analysis in clinical diagnostics and preclinical pathology. HELSINKI, Sept 16, 2021 -- Aiforia, a software company providing AI-based solutions...

Swifter discovery can improve life expectancy A longer life expectancy goes hand in hand with the risk of cancer. The Hamburg-based Mindpeak is developing artificial intelligence to help pathologists diagnose cancer swiftly. Until now,...

What additional benefit does AI bring to the digitized pathology workflow in clinical diagnostics? Read our article to find out. Rising rates of disease like cancer increase sample numbers creating a bigger burden on pathologists, an...

Artificial Intelligence (AI) is transforming clinical pathology. The full potential of AI can only be achieved by the seamless integration of AI in clinical workflows to support pathologists. During this recorded presentation Aiforia’s...